Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Locally advanced prostate cancer imaging findings and implications for treatment from the surgical perspective.

Elsherif SB, Kuchana V, Aslam R, Kamat A, Bhosale PR, Klekers AR.

Abdom Radiol (NY). 2019 Nov 13. doi: 10.1007/s00261-019-02318-3. [Epub ahead of print] Review.

PMID:
31724081
2.

Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy.

Kozikowski M, Zagożdżon B, Gola M, Dobruch J.

Wideochir Inne Tech Maloinwazyjne. 2019 Apr;14(2):262-270. doi: 10.5114/wiitm.2019.83869. Epub 2019 Mar 26.

3.

Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.

Stabile A, Dell'Oglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N, Brembilla G, Cristel G, Cardone G, Deho' F, Losa A, Suardi N, Gaboardi F, Del Maschio A, Montorsi F, Briganti A.

Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.

PMID:
31100225
4.

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.

Radtke JP, Wiesenfarth M, Kesch C, Freitag MT, Alt CD, Celik K, Distler F, Roth W, Wieczorek K, Stock C, Duensing S, Roethke MC, Teber D, Schlemmer HP, Hohenfellner M, Bonekamp D, Hadaschik BA.

Eur Urol. 2017 Dec;72(6):888-896. doi: 10.1016/j.eururo.2017.03.039. Epub 2017 Apr 8.

PMID:
28400169
5.

Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.

Kam J, Yuminaga Y, Krelle M, Gavin D, Koschel S, Aluwihare K, Sutherland T, Skinner S, Brennan J, Wong LM, Louie-Johnsun M.

BJU Int. 2019 Aug;124(2):297-301. doi: 10.1111/bju.14696. Epub 2019 Feb 25.

PMID:
30714285
6.

The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer.

Otti VC, Miller C, Powell RJ, Thomas RM, McGrath JS.

BJU Int. 2019 Jan;123(1):82-90. doi: 10.1111/bju.14420. Epub 2018 Jul 26.

7.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
8.

Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.

Curci NE, Lane BR, Shankar PR, Noyes SL, Moriarity AK, Kubat A, Brede C, Montgomery JS, Auffenberg GB, Miller DC, Montie JE, George AK, Davenport MS.

Urology. 2018 Jun;116:137-143. doi: 10.1016/j.urology.2018.02.043. Epub 2018 Apr 10.

PMID:
29653121
9.

An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines.

Panebianco V, Giganti F, Kitzing YX, Cornud F, Campa R, De Rubeis G, Ciardi A, Catalano C, Villeirs G.

Insights Imaging. 2018 Feb;9(1):87-101. doi: 10.1007/s13244-017-0578-x. Epub 2017 Oct 23. Review.

10.

Central zone lesions on magnetic resonance imaging: Should we be concerned?

Tan WP, Mazzone A, Shors S, Antoine N, Ekbal S, Khare N, McKiel C, Pessis D, Deane L.

Urol Oncol. 2017 Jan;35(1):31.e7-31.e12. doi: 10.1016/j.urolonc.2016.08.006. Epub 2016 Sep 28.

PMID:
27692837
11.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
12.
13.

1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.

Reisæter LA, Fütterer JJ, Halvorsen OJ, Nygård Y, Biermann M, Andersen E, Gravdal K, Haukaas S, Monssen JA, Huisman HJ, Akslen LA, Beisland C, Rørvik J.

Acta Radiol. 2015 Apr;56(4):500-11. doi: 10.1177/0284185114531754. Epub 2014 May 12.

PMID:
24819231
14.

Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.

Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A.

Eur Urol Oncol. 2019 Sep 20. pii: S2588-9311(19)30141-5. doi: 10.1016/j.euo.2019.08.015. [Epub ahead of print]

PMID:
31548130
15.

Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.

Panje C, Panje T, Putora PM, Kim SK, Haile S, Aebersold DM, Plasswilm L.

Radiat Oncol. 2015 Feb 22;10:47. doi: 10.1186/s13014-015-0338-3.

16.

A self-tuned graph-based framework for localization and grading prostate cancer lesions: An initial evaluation based on multiparametric magnetic resonance imaging.

Chen W, Lin M, Gibson E, Bastian-Jordan M, Cool DW, Kassam Z, Liang H, Feng G, Ward AD, Chiu B.

Comput Biol Med. 2018 May 1;96:252-265. doi: 10.1016/j.compbiomed.2018.03.017. Epub 2018 Apr 3.

PMID:
29653354
17.

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

Jansen BHE, Nieuwenhuijzen JA, Oprea-Lager DE, Yska MJ, Lont AP, van Moorselaar RJA, Vis AN.

Urol Oncol. 2019 Mar;37(3):181.e1-181.e6. doi: 10.1016/j.urolonc.2018.10.026. Epub 2018 Dec 15.

PMID:
30558983
18.

Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.

Hansen NL, Kesch C, Barrett T, Koo B, Radtke JP, Bonekamp D, Schlemmer HP, Warren AY, Wieczorek K, Hohenfellner M, Kastner C, Hadaschik B.

BJU Int. 2017 Nov;120(5):631-638. doi: 10.1111/bju.13711. Epub 2016 Dec 21.

19.

Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?

Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.

Clin Genitourin Cancer. 2019 Apr;17(2):88-96. doi: 10.1016/j.clgc.2018.10.006. Epub 2018 Oct 23.

PMID:
30527286
20.

Accuracy of multiparametric MR imaging with PI-RADS V2 assessment in detecting infiltration of the neurovascular bundles prior to prostatectomy.

Sauer M, Weinrich JM, Fraune C, Salomon G, Tennstedt P, Adam G, Beyersdorff D.

Eur J Radiol. 2018 Jan;98:187-192. doi: 10.1016/j.ejrad.2017.11.019. Epub 2017 Nov 27.

PMID:
29279161

Supplemental Content

Support Center